Tyrosine Kinase Inhibitors Chemotherapy Immunotherapy CD Protein Inhibitors Immune Checkpoint Inhibitors | Non Small Cell Lung Cancer | Melanoma | Lung Non-Squamous Non-Small Cell Cancer | Solid Tumor | Glioblastoma |
---|---|---|---|---|---|
crizotinib | |||||
entrectinib | |||||
bevacizumab + atezolizumab | |||||
AB-106 | |||||
repotrectinib | |||||
U3-1402 | |||||
ensartinib | |||||
SAF-189 | |||||
atezolizumab | |||||
bevacizumab + crizotinib | |||||
TQ-B3139 | |||||
durvalumab | |||||
lorlatinib | |||||
SIM1803-1A |